PubRank

Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation

Clinical Trial ID NCT02074839

PubWeight™ 13.43‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02074839

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Emerging therapeutic drugs for AML. Blood 2015 1.04
2 New drugs in acute myeloid leukemia. Ann Oncol 2016 0.88
3 'Acute myeloid leukemia: a comprehensive review and 2016 update'. Blood Cancer J 2016 0.86
4 Digging deep into "dirty" drugs - modulation of the methylation machinery. Drug Metab Rev 2015 0.83
5 Evidence for Clinical Differentiation and Differentiation Syndrome in Patients With Acute Myeloid Leukemia and IDH1 Mutations Treated With the Targeted Mutant IDH1 Inhibitor, AG-120. Clin Lymphoma Myeloma Leuk 2016 0.82
6 Current Approaches in the Treatment of Relapsed and Refractory Acute Myeloid Leukemia. J Clin Med 2015 0.82
7 Epigenetic regulators and their impact on therapy in acute myeloid leukemia. Haematologica 2016 0.78
8 Epigenetic regulators as promising therapeutic targets in acute myeloid leukemia. Ther Adv Hematol 2015 0.78
9 Novel Prognostic and Therapeutic Mutations in Acute Myeloid Leukemia. Cancer Genomics Proteomics 2016 0.77
10 Clinical development of cancer therapeutics that target metabolism. QJM 2015 0.77
11 Small molecule inhibitors in acute myeloid leukemia: from the bench to the clinic. Expert Rev Hematol 2014 0.76
12 IDH1 and IDH2 mutations as novel therapeutic targets: current perspectives. J Blood Med 2016 0.76
13 Defining and Treating Older Adults with Acute Myeloid Leukemia Who Are Ineligible for Intensive Therapies. Front Oncol 2015 0.75
14 Acute myeloid leukemia: advancing clinical trials and promising therapeutics. Expert Rev Hematol 2016 0.75
15 Mutant IDH: a targetable driver of leukemic phenotypes linking metabolism, epigenetics and transcriptional regulation. Epigenomics 2016 0.75
16 When cancer and immunology meet. Immunol Rev 2015 0.75
17 Novel therapeutic options in Acute Myeloid Leukemia. Leuk Res Rep 2016 0.75
Next 100